MDBH,NDRA Stock Price and Quote

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.01
Percentage change -0.16	%

Peers: GS MS JPM BAC C WFC BK USB STT SCHW

| Held by: IWC

Index	-	P/E	-	EPS (ttm)	-2.73	Insider Own	55.21%	Shs Outstand	9.95M	Perf Week	-6.91%
Market Cap	62.09M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.07%	Shs Float	4.46M	Perf Month	0.81%
Income	-24.77M	PEG	-	EPS next Q	-	Inst Own	1.43%	Short Float	0.08%	Perf Quarter	-6.87%
Sales	1.75M	P/S	35.48	EPS this Y	-	Inst Trans	-32.96%	Short Ratio	0.36	Perf Half Y	-19.79%
Book/sh	3.12	P/B	2.00	EPS next Y	-	ROA	-63.79%	Short Interest	0.00M	Perf Year	-48.37%
Cash/sh	1.84	P/C	3.40	EPS next 5Y	-	ROE	-72.85%	52W Range	5.78 - 13.25	Perf YTD	-0.95%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-85.44%	52W High	-52.91%	Beta	1.25
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	47.14%	Gross Margin	-	52W Low	7.96%	ATR (14)	0.42
Dividend Ex-Date	-	Current Ratio	-	EPS Y/Y TTM	-1203.48%	Oper. Margin	-1620.64%	RSI (14)	46.21	Volatility	8.26% 5.61%
Employees	40	Debt/Eq	0.08	Sales Y/Y TTM	-68.06%	Profit Margin	-1417.79%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-178.24%	Payout	-	Rel Volume	1.55	Prev Close	6.25
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	806.33%	Earnings	Nov 21 AMC	Avg Volume	10.41K	Price	6.24
SMA20	-2.41%	SMA50	-5.98%	SMA200	-21.18%	Trades		Volume	16,124	Change	-0.16%

Jan-07-25 10:00AM	Rethinking Diabetes Care: PatentVest Pulse Unveils Key Insights on the Expanding CGM Market and the Innovations Driving Change (GlobeNewswire)
Nov-21-24 04:05PM	MDB Capital Holdings Provides Third Quarter 2024 Update (GlobeNewswire) +7.83% -9.72%
Nov-19-24 09:05AM	Invizyne Technologies Selected for $2 Million Project to Advance Sustainable Aviation Fuel Capabilities (GlobeNewswire)
Nov-15-24 09:05AM	MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time (GlobeNewswire)
Nov-14-24 04:05PM	Invizyne Technologies Announces Closing of Initial Public Offering (GlobeNewswire)
04:05PM	Loading…
Nov-13-24 04:05PM	Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing (GlobeNewswire)
09:05AM	Invizyne Technologies Begins Trading on NASDAQ (GlobeNewswire)
Nov-12-24 10:52AM	Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024 (GlobeNewswire)
Nov-11-24 04:05PM	Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering (GlobeNewswire)
Oct-16-24 12:02PM	MDB Capital Teams with TCA Venture Group to Bring New Insights and Public Venture Opportunities to Angel Investors (GlobeNewswire)
Aug-13-24 10:53PM	MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q2 2024 (InvestorPlace)
Jul-11-24 04:05PM	MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies (GlobeNewswire)
Jul-09-24 11:00AM	Recently Published Whitepaper from PatentVest Delves into Transformative Innovations in MASH Diagnostics (GlobeNewswire)
Jul-08-24 04:16PM	MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform (GlobeNewswire)
Jun-20-24 09:15AM	MDB Capital Expands Board, Appoints Daniel Torpey as New Director (GlobeNewswire)
11:00AM	Loading…
May-22-24 11:00AM	New PatentVest Pulse Report Reveals Transformative Trends in Portable ECG Monitoring (GlobeNewswire)
09:15AM	MDB Capital Holdings Unveils Unified Corporate Branding (GlobeNewswire)
May-13-24 09:55PM	MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q1 2024 (InvestorPlace)
May-07-24 01:52PM	Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq (GlobeNewswire)
Apr-17-24 04:05PM	MDB Capital Holdings Year-End Update (GlobeNewswire)
Apr-11-24 04:05PM	MDB Capital Holdings to Host Fourth Quarter 2023 and Fiscal Year 2023 Results Webinar on Wednesday April 17, 2024 at 4:30 PM Eastern Time (GlobeNewswire)
Apr-02-24 07:53AM	MDBH Stock Earnings: MDB Capital Holdings Reported Results for Q4 2023 (InvestorPlace)
Mar-15-24 02:30PM	Gain Therapeutics to Present at Public Ventures Discovery Day (GlobeNewswire)
Feb-12-24 08:00AM	Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq (GlobeNewswire)
Jan-31-24 09:00AM	MDB Capital Holdings Issues Annual Letter to Shareholders (GlobeNewswire)
Nov-15-23 04:05PM	MDB Capital Holdings Reports Third Quarter 2023 Results (GlobeNewswire)
Nov-08-23 04:05PM	Michael Burns Joins Invizyne as Executive Vice President of Energy Transition (GlobeNewswire)
Nov-02-23 04:05PM	MDB Capital Holdings to Host Third Quarter 2023 Results Conference Call on November 15, 2023 at 4:30 PM Eastern Time (GlobeNewswire)
Oct-17-23 10:00AM	Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort (GlobeNewswire)
Oct-11-23 11:10AM	Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy (GlobeNewswire)
09:00AM	Loading…
Sep-21-23 09:00AM	MDB Capital Holdings Begins Trading on NASDAQ (ACCESSWIRE)

MDB Capital Holdings LLC is an investment holding company, which engages the provision of a foundational platform specializing in financing startups, partnering with co-founders, and fostering significant value creation. It operates through the following segments: Broker Dealer and Intellectual Property Service, Technology Development, and Other. The Broker Dealer and Intellectual Property Service segment includes Public Ventures and PatentVest. The Technology Development segment is involved in Invizyne. The Other segment focuses on non-income generating subsidiaries for management of the business including MDB CG Management Company, Inc. The company was founded by Christopher Anthony Marlett in 1997 and is headquartered in Addison, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DIGIANDOMENICO ANTHONY	Co-Founder	Jan 13 '25	Buy	6.23	1,000	6,230	81,709	Jan 15 06:28 PM
DIGIANDOMENICO ANTHONY	Co-Founder	Jan 14 '25	Buy	6.17	1,000	6,170	83	Jan 15 06:28 PM
DIGIANDOMENICO ANTHONY	Co-Founder	Jan 15 '25	Buy	6.04	1,000	6,040	83,709	Jan 15 06:28 PM
DIGIANDOMENICO ANTHONY	Co-Founder	Jan 03 '25	Buy	6.25	16	100	80,709	Jan 07 08:20 PM
Brandon George Hugh	President	Oct 21 '24	Option Exercise	6.81	100,000	681,000	100,000	Dec 20 12:36 PM
HAYAT MOHAMMAD	Chief Legal Officer	Oct 21 '24	Option Exercise	6.81	100,000	681,000	100,000	Dec 20 12:36 PM
Magennis Sean James	Director	Oct 21 '24	Option Exercise	6.81	20,000	136,200	20,000	Dec 20 12:36 PM
DIGIANDOMENICO ANTHONY	Co-Founder	Oct 21 '24	Option Exercise	6.81	50,000	340,500	76,645	Dec 20 12:36 PM
MARLETT CHRISTOPHER A	CEO	Oct 21 '24	Option Exercise	6.81	50,000	340,500	129,993	Dec 20 12:36 PM
Hayden Matthew	Director	Oct 21 '24	Option Exercise	6.81	40,000	272,400	40,000	Dec 20 12:36 PM
Meline Susanne	Director	Oct 21 '24	Option Exercise	6.81	20,000	136,200	20,000	Dec 20 12:36 PM
James Jeremy William	CFO	Oct 21 '24	Option Exercise	6.81	20,000	136,200	20,000	Nov 29 02:24 PM
James Jeremy William	CFO	Nov 26 '24	Sale	8.21	4,161	34,182	15,839	Nov 29 02:24 PM
James Jeremy William	CFO	Nov 27 '24	Sale	7.74	2,500	19,340	13,339	Nov 29 02:24 PM
Jeremy James	Officer	Nov 25 '24	Proposed Sale	6.16	20,000	123,200		Nov 22 02:53 PM

Dollar change +0.08
Percentage change 1.35	%

NDRA ENDRA Life Sciences Inc daily Stock Chart

Peers: DXCM TTOO BFLY CDNA AXDX XGN MRSN APDN CASI

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-1172.20	Insider Own	0.02%	Shs Outstand	-	Perf Week	0.50%
Market Cap	3.23M	Forward P/E	-	EPS next Y	-15.38	Insider Trans	-	Shs Float	0.54M	Perf Month	36.90%
Income	-8.82M	PEG	-	EPS next Q	-4.10	Inst Own	1.15%	Short Float	9.66%	Perf Quarter	-18.23%
Sales	0.00M	P/S	-	EPS this Y	98.28%	Inst Trans	204.95%	Short Ratio	0.19	Perf Half Y	-95.82%
Book/sh	432.19	P/B	0.01	EPS next Y	67.59%	ROA	-110.35%	Short Interest	0.05M	Perf Year	-99.72%
Cash/sh	8.84	P/C	0.68	EPS next 5Y	-	ROE	-149.45%	52W Range	4.01 - 2240.00	Perf YTD	-3.99%
Dividend Est.	-	P/FCF	-	EPS past 5Y	48.47%	ROI	-132.52%	52W High	-99.73%	Beta	0.51
Dividend TTM	-	Quick Ratio	6.10	Sales past 5Y	0.00%	Gross Margin	-	52W Low	49.88%	ATR (14)	0.65
Dividend Ex-Date	-	Current Ratio	6.10	EPS Y/Y TTM	76.05%	Oper. Margin	-	RSI (14)	51.58	Volatility	5.41% 11.75%
Employees	21	Debt/Eq	0.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	75.00
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	52.73%	Payout	-	Rel Volume	0.04	Prev Close	5.93
Sales Surprise	-	EPS Surprise	84.69%	Sales Q/Q	-	Earnings	Nov 15 BMO	Avg Volume	272.15K	Price	6.01
SMA20	1.82%	SMA50	7.26%	SMA200	-96.15%	Trades		Volume	10,780	Change	1.35%

Nov-22-24 08:00AM	ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement (Business Wire)
Nov-15-24 09:24AM	ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -14.18%
Nov-12-24 08:00AM	Study Highlighting ENDRA Life Sciences' TAEUS Technology in Patients with High BMI to be Presented at AASLD's The Liver Meeting 2024 (Business Wire)
Nov-06-24 08:00AM	ENDRA Life Sciences Further Strengthens TAEUS Platform Intellectual Property with Issuance of 17th European Patent (Business Wire) -14.84%
Oct-22-24 08:00AM	ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany (Business Wire) +89.19%
04:17PM	Loading…
Aug-28-24 04:17PM	ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements (Business Wire) -19.56%
Aug-22-24 04:14PM	ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -10.99%
Aug-16-24 08:00AM	ENDRA Life Sciences Announces Reverse Stock Split (Business Wire) -22.50%
Aug-13-24 04:05PM	ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024 (Business Wire)
08:00AM	ENDRA Life Sciences Announces Leadership Changes (Business Wire)
Aug-07-24 08:00AM	ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14 (Business Wire)
Jun-17-24 08:11AM	Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today? (InvestorPlace) +34.17%
07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Jun-05-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +63.41%
Jun-04-24 09:21AM	ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering (Business Wire) -60.83%
08:00AM	Loading…
May-20-24 08:00AM	ENDRA Provides Update Following In-person Meeting with FDA (Business Wire)
May-15-24 03:10AM	ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-14-24 04:05PM	ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update (Business Wire)
May-07-24 08:00AM	ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024 (Business Wire) -6.41%
May-02-24 08:00AM	ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents (Business Wire) +15.48%
Apr-01-24 09:59AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript (Insider Monkey) -30.50%
Mar-29-24 06:21AM	Q4 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	NDRA Stock Earnings: ENDRA Life Sciences Beats EPS for Q4 2023 (InvestorPlace) -29.29% -30.50%
04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-24 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 (Business Wire) -8.76%
Feb-27-24 08:00AM	ENDRA Life Sciences Installs First TAEUS System in the UK (Business Wire)
Feb-21-24 08:00AM	New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences TAEUS System (Business Wire)
Feb-14-24 08:30AM	ENDRA Life Sciences Bolsters TAEUS System Intellectual Property with New Patents in U.S., China and Europe (Business Wire)
Nov-29-23 08:00AM	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS System Technology (Business Wire)
Nov-27-23 08:00AM	ENDRA Life Sciences to Participate in The Benchmark Companys 12th Annual Discovery One-on-One Investor Conference (Business Wire)
01:23PM	Loading…
Nov-15-23 01:23PM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-14-23 04:05PM	ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Nov-08-23 08:00AM	ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents (Business Wire)
Nov-07-23 04:05PM	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023 (Business Wire)
Nov-06-23 08:00AM	ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLDs The Liver Meeting 2023 (Business Wire)
Sep-07-23 08:00AM	Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023 (Business Wire)
Aug-30-23 08:00AM	ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA (Business Wire) +6.31%
Aug-23-23 08:00AM	ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents (Business Wire)
Aug-20-23 11:20AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 06:49AM	Q2 2023 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -8.37%
Aug-14-23 04:05PM	ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update (Business Wire)
01:30PM	ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA (Business Wire)
Aug-01-23 08:00AM	ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023 (Business Wire)
Jul-12-23 05:15PM	Domino's Pizza teams up with Uber for food delivery partnership (Yahoo Finance Video)
03:27PM	Stocks to Watch Wednesday: Domino's, Coty, Activision, Lucid (The Wall Street Journal)
02:42PM	Analyst Report: Domino's Pizza, Inc. (Morningstar Research)
02:01PM	Domino's stock jumps on partnership with Uber Eats (Yahoo Finance)
12:31PM	Dominos Pizza Is Todays Hottest Stock (The Wall Street Journal)
10:30AM	Domino's Pizza stock jumps on delivery partnership with Uber (Yahoo Finance Video)
09:42AM	Dominos Pizza Is This Mornings Hottest Stock (The Wall Street Journal)
07:05AM	Domino's® Introduces a New Way to Order Using Uber Eats Marketplace (PR Newswire)
Jul-06-23 04:45PM	ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023 (Business Wire)
Jun-07-23 08:00AM	Study Highlighting ENDRA Life Sciences TAEUS Technology to be Presented at EASL International Liver Congress 2023 (Business Wire) +5.33%
May-15-23 04:05PM	ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update (Business Wire) -8.57%
May-04-23 08:00AM	ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023 (Business Wire) +8.70%
May-02-23 04:01PM	ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Securities (Business Wire) +17.24% -5.29%
Apr-28-23 08:00AM	ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering (Business Wire) +24.03%
Mar-17-23 05:00AM	ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.00%
Mar-15-23 10:32AM	Q4 2022 ENDRA Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-23 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-07-23 04:05PM	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023 (Business Wire)
Dec-08-22 09:55AM	Here's Why ENDRA Life Sciences Inc. (NDRA) Could be Great Choice for a Bottom Fisher (Zacks) +6.79%
Dec-05-22 08:00AM	ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split (Business Wire) -12.10%
Nov-14-22 04:05PM	ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -10.22%
Nov-09-22 08:00AM	ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022 (Business Wire) -7.51%
Oct-25-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents (Business Wire)
Oct-04-22 08:00AM	ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference (Business Wire)
Sep-29-22 04:05PM	ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks (Business Wire)
Sep-06-22 08:00AM	ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences (Business Wire)
Aug-24-22 08:40AM	ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System (Business Wire) +11.62%
Aug-15-22 04:30PM	Edited Transcript of NDRA.OQ earnings conference call or presentation 15-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents) -7.87%
04:05PM	ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-08-22 10:16AM	Here's Why ENDRA Life Sciences (NASDAQ:NDRA) Must Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-02-22 08:00AM	ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices (Business Wire)
Aug-01-22 08:00AM	ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference (Business Wire) +14.63%
Jul-11-22 08:00AM	ENDRA Life Sciences Awarded Two Additional Chinese Patents for its TAEUS® System (Business Wire)
Jun-28-22 08:00AM	ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent (Business Wire) +7.11%
Jun-08-22 08:00AM	ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference (Business Wire) +6.97%
May-25-22 08:00AM	ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent (Business Wire)
May-16-22 08:00AM	ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference (Business Wire)
May-12-22 04:05PM	ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-10-22 08:00AM	ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System (Business Wire)
May-02-22 08:00AM	ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022 (Business Wire)
Apr-21-22 08:00AM	ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility (Business Wire)
Mar-31-22 08:00AM	ENDRA Life Sciences Achieves Key Quality Management System Certification (Business Wire)
Mar-30-22 04:05PM	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +8.37%
09:12AM	ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents (Business Wire)
Mar-22-22 08:00AM	ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022 (Business Wire)
Mar-09-22 08:00AM	ENDRA Life Sciences to Participate in Two March Investor Conferences (Business Wire) +11.02%
Mar-08-22 08:00AM	ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent (Business Wire)
Feb-15-22 08:55AM	The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R)) (Newsfile) +11.59%
Feb-11-22 08:00AM	ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents (Business Wire) -9.28%
Feb-10-22 07:10AM	ENDRA Life Voluntarily Withdraws 510(k) Application For Liver Fat Measuring System (Benzinga) -20.30%
Feb-09-22 04:05PM	ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System (Business Wire)
Jan-24-22 08:15AM	ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership (Business Wire)
Jan-05-22 07:00AM	ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Dec-30-21 07:57AM	Forget Bargains, Play 5 Stocks With Rising P/E Instead (Zacks)
Dec-13-21 08:00AM	ENDRA Life Sciences Announces New Clinical Study Partnership with Kings College Hospital, London (Business Wire) -6.98%
Nov-29-21 08:00AM	ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study (Business Wire)

ENDRA Life Sciences, Inc. develops medical imaging technology. It operates Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
UBS Group AG	10% Owner	Aug 27 '24	Buy	0.55	3,715	2,052	146,012	Aug 29 04:30 PM

MDBH

MDB Capital Holdings LLC

NDRA

ENDRA Life Sciences Inc

Upgrade your FINVIZ experience